Trade Ocular Therapeutix Inc - OCUL CFD
Add to favourite- Summary
- Historical Data
Spread | 0.07 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 4.76 |
Open | 4.63 |
1-Year Change | -24.96% |
Day's Range | 4.63 - 4.92 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 29, 2024 | 4.76 | 0.05 | 1.06% | 4.71 | 5.15 | 4.69 |
Apr 26, 2024 | 4.71 | 0.64 | 15.72% | 4.07 | 4.75 | 4.04 |
Apr 25, 2024 | 4.17 | -0.22 | -5.01% | 4.39 | 4.49 | 4.13 |
Apr 24, 2024 | 4.61 | -0.32 | -6.49% | 4.93 | 4.97 | 4.53 |
Apr 23, 2024 | 4.96 | -0.12 | -2.36% | 5.08 | 5.12 | 4.93 |
Apr 22, 2024 | 5.04 | -0.17 | -3.26% | 5.21 | 5.43 | 4.95 |
Apr 19, 2024 | 5.18 | -0.55 | -9.60% | 5.73 | 5.75 | 4.94 |
Apr 18, 2024 | 5.82 | -1.71 | -22.71% | 7.53 | 7.53 | 5.82 |
Apr 17, 2024 | 7.55 | -0.33 | -4.19% | 7.88 | 8.06 | 7.55 |
Apr 16, 2024 | 7.76 | 0.16 | 2.11% | 7.60 | 7.89 | 7.53 |
Apr 15, 2024 | 7.78 | 0.02 | 0.26% | 7.76 | 7.93 | 7.54 |
Apr 12, 2024 | 7.94 | -0.31 | -3.76% | 8.25 | 8.30 | 7.84 |
Apr 11, 2024 | 8.23 | 0.25 | 3.13% | 7.98 | 8.26 | 7.80 |
Apr 10, 2024 | 7.87 | 0.18 | 2.34% | 7.69 | 7.98 | 7.56 |
Apr 9, 2024 | 8.14 | 0.22 | 2.78% | 7.92 | 8.14 | 7.91 |
Apr 8, 2024 | 7.96 | -0.78 | -8.92% | 8.74 | 8.81 | 7.90 |
Apr 5, 2024 | 8.40 | -0.02 | -0.24% | 8.42 | 8.71 | 8.27 |
Apr 4, 2024 | 8.44 | -0.14 | -1.63% | 8.58 | 8.91 | 8.35 |
Apr 3, 2024 | 8.42 | 0.02 | 0.24% | 8.40 | 8.52 | 8.27 |
Apr 2, 2024 | 8.44 | -0.01 | -0.12% | 8.45 | 8.64 | 8.30 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Ocular Therapeutix Inc Company profile
About Ocular Therapeutix Inc
Ocular Therapeutix, Inc. is a biopharmaceutical company, which is focused on the formulation, development and commercialization of therapies for diseases and conditions of the eye using its proprietary, bioresorbable hydrogel platform technology. The Company’s product pipeline candidates provide differentiated drug delivery solutions. The Company’s products include dexamethasone insert (DEXTENZA) and ReSure Sealant. Its DEXTENZA is an intracanalicular insert for the treatment of post-surgical ocular inflammation and pain. Its ReSure Sealant is an ophthalmic device designed to prevent wound leaks in corneal incisions following cataract surgery. The Company’s products that are in pipeline include OTX-TKI for the treatment of wet AMD, OTX-TIC for the treatment of glaucoma and ocular hypertension, OTX-CSI for the chronic treatment of dry eye disease, and OTX-DED for the short-term treatment of the signs and symptoms of dry eye disease.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Ocular Therapeutix Inc revenues increased from $17.4M to $43.5M. Net loss decreased 96% to $6.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Change in fair value of derivative liab. increase from $86.2M (expense) to $78.1M (income), Interest Expense decrease of 1% to $6.7M (expense).
Industry: | Pharmaceuticals (NEC) |
24 Crosby Drive
BEDFORD
MASSACHUSETTS 01730
US
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com